Results 211 to 220 of about 17,275 (222)

New poliovirus vaccine schedules – Authors' reply

Lancet, The, 2016
Edwin Jose Asturias, Walter Orenstein
exaly  

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

Ca-A Cancer Journal for Clinicians, 2007
Philip Castle, Philip E Castle, Diane M Harper   +2 more
exaly  

Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies

Lancet, The, 2003
Peter Aaby, Morten Sodemann, Anja Poulsen   +2 more
exaly  

[Prevention of vaccine derived poliovirus transmission].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2009
openaire   +1 more source

Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial

Lancet, The, 2019
Concepción F Estívariz, William C Weldon, Mark A Pallansch   +2 more
exaly  

Two Cases of Vaccine-Derived Poliovirus Infection in an Oncology Ward

New England Journal of Medicine, 2016
Anna M Eis-Hübinger
exaly  

Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine

New England Journal of Medicine, 2018
Isobel M Blake, Margarita Pons-Salort, Ananda Bandyopadhyay   +2 more
exaly  

Parameters for differentiating vaccine-derived and wild poliovirus strains.

Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale, 1978
J H, Nakano, M H, Hatch, M L, Thieme, B, Nottay   +3 more
openaire   +1 more source

First Africa-based clinical trial for novel type 2 oral poliovirus vaccine

Lancet, The
Laura Cooper, Isobel M Blake
exaly  

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine

Lancet, The, 1993
exaly